
Uttranchal Pharmaceuticals Private Limited
Pharmaceutical company manufacturing and trading various types of medicines and medical equipment.
Pharmaceutical company manufacturing and trading various types of medicines and medical equipment.
Uttranchal Pharmaceuticals Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 July 2005 and has a history of 19 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹2.70 Cr. The company has closed loans amounting to ₹2.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nitha and Kathiravanathan serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
U24232DL2005PTC138489
138489
Private Limited Indian Non-Government Company
08 Jul 2005
21 Sep 2024
31 Mar 2024
Unlisted
Roc Delhi
Uttranchal Pharmaceuticals Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antiemetic, Antacid Drugs, Cardiovascular Drugs & Medication, Diabetes Medicine.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kathiravanathan ![]() | Managing Director | 20-Jan-2015 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nitha ![]() | Director | 20-Jan-2015 | Current |
Uttranchal Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.82% increase. The company also saw a substantial fall in profitability, with a 36.63% decrease in profit. The company's net worth moved up by a moderate rise of 4.93%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Uttranchal Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹27.00 M
₹23.51 M
Date | Lender | Amount | Status |
---|---|---|---|
27 May 2023 | Axis Bank Limited | ₹2.70 Cr | Open |
17 May 2022 | Hdfc Bank Limited | ₹1.42 Cr | Satisfied |
16 Jun 2020 | Others | ₹1.31 M | Satisfied |
15 Apr 2015 | Punjab National Bank | ₹8.00 M | Satisfied |
Unlock and access historical data on people associated with Uttranchal Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Uttranchal Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uttranchal Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Uttranchal Pharmaceuticals Private Limited last Annual general meeting of members was held on 21 Sep 2024 as per latest MCA records.
Uttranchal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
A charge registered on 17 May 2022 via Charge ID 100576801 with Hdfc Bank Limited was fully satisfied on 15 Jun 2023.
A charge with Axis Bank Limited amounted to Rs. 27.00 M with Charge ID 100730026 was registered on 27 May 2023.
A charge with Hdfc Bank Limited amounted to Rs. 14.20 M with Charge ID 100576801 was registered on 17 May 2022.
A charge registered on 16 Jun 2020 via Charge ID 100360681 with Others was fully satisfied on 11 May 2022.
Uttranchal Pharmaceuticals Private Limited was incorporated on 08 Jul 2005.
The authorized share capital of Uttranchal Pharmaceuticals Private Limited is ₹ 7.00 M and paid-up capital is ₹ 7.00 M.
Currently 2 directors are associated with Uttranchal Pharmaceuticals Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Uttranchal Pharmaceuticals Private Limited is B-737 Gali No.24, Sant Nagar Burari India, New Delhi, 110084.
The corporate identification number (CIN) of Uttranchal Pharmaceuticals Private Limited is U24232DL2005PTC138489 and the company number is 138489 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Uttranchal Pharmaceuticals Private Limited has risen by 1.82%.
The financial reports for the fiscal year 2023 indicates that The net worth of Uttranchal Pharmaceuticals Private Limited has experienced an upsurge of 4.93%.
As per the financial statements for fiscal Year 2023, The total open charges for Uttranchal Pharmaceuticals Private Limited amount to ₹ 2.70 Cr.
The most recent Balance Sheet for Uttranchal Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
MA
SK
KN
HN